Incyte Corp (INCY)
53.23
+0.14
(+0.26%)
USD |
NASDAQ |
May 03, 14:04
Incyte Cash from Financing (Quarterly): -12.41M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -12.41M |
| December 31, 2023 | 0.346M |
| September 30, 2023 | -37.26M |
| June 30, 2023 | 12.87M |
| March 31, 2023 | 4.009M |
| December 31, 2022 | -2.48M |
| September 30, 2022 | -14.31M |
| June 30, 2022 | 15.90M |
| March 31, 2022 | 0.096M |
| December 31, 2021 | 9.005M |
| September 30, 2021 | -19.34M |
| June 30, 2021 | 3.679M |
| March 31, 2021 | 12.84M |
| December 31, 2020 | 11.87M |
| September 30, 2020 | 0.931M |
| June 30, 2020 | 56.41M |
| March 31, 2020 | 2.499M |
| December 31, 2019 | 29.32M |
| September 30, 2019 | 2.894M |
| June 30, 2019 | 9.01M |
| March 31, 2019 | 4.487M |
| December 31, 2018 | 4.063M |
| September 30, 2018 | 2.437M |
| June 30, 2018 | 5.562M |
| March 31, 2018 | 2.595M |
| Date | Value |
|---|---|
| December 31, 2017 | 3.724M |
| September 30, 2017 | 653.99M |
| June 30, 2017 | 10.53M |
| March 31, 2017 | 21.96M |
| December 31, 2016 | -0.151M |
| September 30, 2016 | 7.126M |
| June 30, 2016 | 27.76M |
| March 31, 2016 | 9.884M |
| December 31, 2015 | 7.286M |
| September 30, 2015 | 13.61M |
| June 30, 2015 | 31.16M |
| March 31, 2015 | 32.69M |
| December 31, 2014 | 29.10M |
| September 30, 2014 | 6.644M |
| June 30, 2014 | 12.78M |
| March 31, 2014 | 44.54M |
| December 31, 2013 | 230.93M |
| September 30, 2013 | 26.87M |
| June 30, 2013 | 0.009M |
| March 31, 2013 | 17.78M |
| December 31, 2012 | 7.482M |
| September 30, 2012 | 8.914M |
| June 30, 2012 | 17.89M |
| March 31, 2012 | 13.42M |
| December 31, 2011 | 1.754M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-37.26M
Minimum
Sep 2023
56.41M
Maximum
Jun 2020
4.293M
Average
3.286M
Median
Cash from Financing (Quarterly) Benchmarks
| Biogen Inc | -439.60M |
| Novartis AG | -5.164B |
| MorphoSys AG | -- |
| Illumina Inc | -27.00M |
| Pfizer Inc | 5.442B |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 218.81M |
| Cash from Investing (Quarterly) | -73.11M |
| Free Cash Flow | 790.77M |
| Free Cash Flow Per Share (Quarterly) | 0.921 |
| Free Cash Flow to Equity (Quarterly) | 209.26M |
| Free Cash Flow to Firm (Quarterly) | 209.26M |
| Free Cash Flow Yield | 6.56% |